|
The use of Antenatal clinics, and IPT by pregnant women* |
|
| Characteristic |
n (%) |
|
|
|
| No. with ANC card* |
351 (46.0%) |
| Number visiting ANC at least once |
722 (94.4%) |
| No. visiting ANC at least twice |
676 (88.4%) |
| Median No. of ANC visits (quartiles) |
3 (2–4) |
| Timing of ANC visits |
|
| Median month of 1st visit (quartiles) |
5.7 (1.6) |
| Median month of 2nd visit (quartiles) |
6.8 (1.3) |
| Median month of 3rd visit (quartiles) |
7.7 (1.1) |
| Median month of 4th visit (quartiles) |
8.3 (1.0) |
| Place of ANC attendance |
|
| TBA |
12 (1.6%) |
| Private clinic |
134 (18.2%) |
| HC II |
101 (13.7%) |
| HC III |
332 (45.2%) |
| HC IV |
45 (6.1%) |
| Hospital |
111 (15.2%) |
| IPTp-SP |
|
| Took no IPTp-SP |
215 (28.5%) |
| Took one dose of IPTp-SP |
265 (35.3%) |
| Took more than one dose IPTp-SP |
272 (36.2%) |
| Gestational age 1st IPTp-SP dose, mo† |
|
| <4 |
14 (2.6%) |
| 4–7 |
438 (81.6%) |
| 7.1–8.5 |
73 (13.6%) |
| >8.5 |
12 (2.2%) |
| Gestational age 2nd IPTp-SP dose, mo† |
|
| 4–7 |
121 (45%) |
| 8–8.5 |
108 (40%) |
| >8.5 |
40 (15%) |
|
IPTp-SP indicates intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy. *Sixteen women did not know if they received SP in the ANC. † < 4 mo (1st trimester), 4–7 mo (2nd trimester), 7.1–8.5 mo (early 3rd trimester), >8.5 (late 3rd trimester) | |
Kiwuwa and Mufubenga Malaria Journal 2008 7:44 doi:10.1186/1475-2875-7-44 |
|